Bs. Huang et Fhh. Leenen, Brain renin-angiotensin system and ouabain-induced sympathetic hyperactivity and hypertension in Wistar rats, HYPERTENSIO, 34(1), 1999, pp. 107-112
Citations number
32
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
In Dahl salt-sensitive rats on a high salt diet or normotensive rats with c
hronic central infusion of sodium, increased brain "ouabain" results in sym
pathetic hyperactivity and hypertension, possibly by activating the brain r
enin-angiotensin system. In the present study, we tested whether the hypert
ension caused by exogenous ouabain also depends on activation of brain reni
n-angiotensin system. In Wistar rats, ouabain (50 mu g/d) was infused subcu
taneously for 14 days with the use of osmotic minipumps. Concomitantly, in
one group, the angiotensin II type 1 receptor blocker losartan (1 mg/kg per
day) was infused intracerebroventricularly. On day 15, mean arterial press
ure, heart rate, central venous pressure, and renal sympathetic nerve activ
ity were recorded in conscious rats at rest and in response to air-jet stre
ss, intracerebroventricular injection of the alpha(2)-agonist guanabenz (25
and 75 mu g) or angiotensin II (30 ng), acute volume expansion, and ramp c
hanges of blood pressure by +/-50 mmHg with phenylephrine and nitroprusside
. Compared with control rats, in rats treated with ouabain, resting mean ar
terial pressure was significantly increased (111+/-4 versus 93+/-3 mm Hg; P
<0.05), and increases or decreases in mean arterial pressure, heart rate, a
nd renal sympathetic nerve activity in response to air stress or guanabenz
were enhanced significantly. These effects of ouabain were prevented when l
osartan was given concomitantly. Maximal slopes of arterial baroreflex cont
rol of renal sympathetic nerve activity and heart rate tended to be decreas
ed in ouabain-treated versus control rats and were significantly increased
in ouabain-treated rats with versus without losartan. No differences in car
diopulmonary baroreflex function were detected. It seems that by day 14 to
15, the central effect of ouabain on baroreflex control prevails over its p
eripheral sensitizing effect on baroreceptors, leading to a tendency of des
ensitization. These results indicate that chronic administration of ouabain
activates the brain renin-angiotensin system, resulting in decreased sympa
thoinhibition and increased sympathoexcitation, impairment of baroreflex fu
nction, and hypertension.